Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME58380FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Harvard Bioscience Inc (HBIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. The company markets products directly in the US, the UK, Germany, France, Sweden, Canada, Italy, Spain and China; and also through a network of distributors in other countries. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience Inc Key Recent Developments

Feb 18,2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22,2020: Harvard Bioscience announces new credit facility
Nov 05,2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05,2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20,2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Harvard Bioscience Inc – Key Facts
Harvard Bioscience Inc – Key Employees
Harvard Bioscience Inc – Key Employee Biographies
Harvard Bioscience Inc – Major Products and Services
Harvard Bioscience Inc – History
Harvard Bioscience Inc – Company Statement
Harvard Bioscience Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Harvard Bioscience Inc – Business Description
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Harvard Bioscience Inc – Corporate Strategy
Harvard Bioscience Inc – SWOT Analysis
SWOT Analysis – Overview
Harvard Bioscience Inc – Strengths
Harvard Bioscience Inc – Weaknesses
Harvard Bioscience Inc – Opportunities
Harvard Bioscience Inc – Threats
Harvard Bioscience Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22, 2020: Harvard Bioscience announces new credit facility
Nov 05, 2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05, 2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20, 2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
May 05, 2020: Harvard Bioscience announces first quarter 2020 financial results
Apr 18, 2020: HARVARD BIOSCIENCE receives loan under Paycheck Protection Program
Apr 06, 2020: Harvard Bioscience announces appointment of Susan Steele to board of directors
Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results
Feb 11, 2020: Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Harvard Bioscience Inc, Key Facts
Harvard Bioscience Inc, Key Employees
Harvard Bioscience Inc, Key Employee Biographies
Harvard Bioscience Inc, Major Products and Services
Harvard Bioscience Inc, History
Harvard Bioscience Inc, Subsidiaries
Harvard Bioscience Inc, Key Competitors
Harvard Bioscience Inc, Ratios based on current share price
Harvard Bioscience Inc, Annual Ratios
Harvard Bioscience Inc, Annual Ratios (Cont...1)
Harvard Bioscience Inc, Annual Ratios (Cont...2)
Harvard Bioscience Inc, Interim Ratios
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greif Inc (GEF):企業の財務・戦略的SWOT分析
    Greif Inc (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aviation Industry Corporation of China:企業の戦略・SWOT・財務情報
    Aviation Industry Corporation of China - Strategy, SWOT and Corporate Finance Report Summary Aviation Industry Corporation of China - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Grupo Financiero Galicia S.A. (GGAL3):企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia S.A. (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Awilco LNG ASA (ALNG):企業の財務・戦略的SWOT分析
    Summary Awilco LNG ASA (Awilco LNG), a subsidiary of Awilhelmsen AS, is an oil and gas company that provides LNG transportation programs. The company owns and operates LNG vessels intended for international trading. It offers LNG value chain such as liquefaction, production, regasification, transpor …
  • Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sequa Petroleum NV:石油・ガス:M&Aディール及び事業提携情報
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company that develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Kazakhstan, North Western Europe and Sub Saharan Africa. Its Kazakhstan exploration site is located in Aksai block …
  • Fluor Corp (FLR)
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Keio Corporation:企業の戦略・SWOT・財務分析
    Keio Corporation - Strategy, SWOT and Corporate Finance Report Summary Keio Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務分析
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Melbana Energy Ltd (MAY):石油・ガス:M&Aディール及び事業提携情報
    Summary Melbana Energy Ltd (Melbana), formerly MEO Australia Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of oil and gas properties. Its projects include Cuba – Block 9 PSC, Taranaki Basin, Petrel Sub-Basin Exploration, T …
  • Bajaj Finance Ltd (BAJFINANCE):企業の財務・戦略的SWOT分析
    Bajaj Finance Ltd (BAJFINANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pharm-Olam International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization that offers clinical research services. The organization’s services include clinical trials, medical writing, medical monitoring, regulatory submissions, data management, biostatistics analysis, pharmacovigilance, …
  • The Royal Bank of Scotland Group Plc:企業のM&A・事業提携・投資動向
    The Royal Bank of Scotland Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Royal Bank of Scotland Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Cowen Inc:企業のM&A・事業提携・投資動向
    Cowen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cowen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務分析
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Jinchuan Group International Resources Co. Ltd:企業の戦略・SWOT・財務情報
    Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆